These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 31578216

  • 1. Cardiac and Stress Biomarkers and Chronic Kidney Disease Progression: The CRIC Study.
    Bansal N, Zelnick L, Shlipak MG, Anderson A, Christenson R, Deo R, deFilippi C, Feldman H, Lash J, He J, Kusek J, Ky B, Seliger S, Soliman EZ, Go AS, CRIC Study Investigators.
    Clin Chem; 2019 Nov; 65(11):1448-1457. PubMed ID: 31578216
    [Abstract] [Full Text] [Related]

  • 2. Cardiac Biomarkers and Risk of Atherosclerotic Cardiovascular Disease in Patients with CKD.
    Lidgard B, Zelnickv L, Anderson AH, Feldman H, Go A, He J, Kansal M, Mohanty MJ, Mehta R, Shlipak MG, Soliman E, Weir MR, Bansal N, CRIC Study Investigators*.
    Kidney360; 2022 May 26; 3(5):859-871. PubMed ID: 36128494
    [Abstract] [Full Text] [Related]

  • 3. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
    Bansal N, Katz R, Dalrymple L, de Boer I, DeFilippi C, Kestenbaum B, Park M, Sarnak M, Seliger S, Shlipak M.
    Clin J Am Soc Nephrol; 2015 Feb 06; 10(2):205-14. PubMed ID: 25605700
    [Abstract] [Full Text] [Related]

  • 4. Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure.
    Tummalapalli SL, Zelnick LR, Andersen AH, Christenson RH, deFilippi CR, Deo R, Go AS, He J, Ky B, Lash JP, Seliger SL, Soliman EZ, Shlipak MG, Bansal N, CRIC Study Investigators †.
    J Am Heart Assoc; 2020 Jul 07; 9(13):e014385. PubMed ID: 32578483
    [Abstract] [Full Text] [Related]

  • 5. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
    Tuegel C, Katz R, Alam M, Bhat Z, Bellovich K, de Boer I, Brosius F, Gadegbeku C, Gipson D, Hawkins J, Himmelfarb J, Ju W, Kestenbaum B, Kretzler M, Robinson-Cohen C, Steigerwalt S, Bansal N.
    Am J Kidney Dis; 2018 Oct 07; 72(4):519-528. PubMed ID: 29866459
    [Abstract] [Full Text] [Related]

  • 6. Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Bansal N, Zelnick LR, Soliman EZ, Anderson A, Christenson R, DeFilippi C, Deo R, Feldman HI, He J, Ky B, Kusek J, Lash J, Seliger S, Shafi T, Wolf M, Go AS, Shlipak MG, CRIC Study Investigators.
    Am J Kidney Dis; 2021 Jun 07; 77(6):907-919. PubMed ID: 33309861
    [Abstract] [Full Text] [Related]

  • 7. High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Bansal N, Hyre Anderson A, Yang W, Christenson RH, deFilippi CR, Deo R, Dries DL, Go AS, He J, Kusek JW, Lash JP, Raj D, Rosas S, Wolf M, Zhang X, Shlipak MG, Feldman HI.
    J Am Soc Nephrol; 2015 Apr 07; 26(4):946-56. PubMed ID: 25278510
    [Abstract] [Full Text] [Related]

  • 8. Cardiac Biomarkers and Risk of Incident Heart Failure in Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Bansal N, Zelnick L, Go A, Anderson A, Christenson R, Deo R, Defilippi C, Lash J, He J, Ky B, Seliger S, Soliman E, Shlipak M, CRIC Study Investigators †, CRIC Study Investigators<xref ref-type="author-note" rid="jah34503-note-1002"><sup>†</sup></xref>.
    J Am Heart Assoc; 2019 Nov 05; 8(21):e012336. PubMed ID: 31645163
    [Abstract] [Full Text] [Related]

  • 9. Upper Reference Limits for High-Sensitivity Cardiac Troponin T and N-Terminal Fragment of the Prohormone Brain Natriuretic Peptide in Patients With CKD.
    Bansal N, Zelnick LR, Ballantyne CM, Chaves PHM, Christenson RH, Coresh J, deFilippi CR, de Lemos JA, Daniels LB, Go AS, He J, Hedayati SS, Matsushita K, Nambi V, Shlipak MG, Taliercio JJ, Seliger SL, CRIC Study Investigators.
    Am J Kidney Dis; 2022 Mar 05; 79(3):383-392. PubMed ID: 34293394
    [Abstract] [Full Text] [Related]

  • 10. Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes.
    Resl M, Clodi M, Vila G, Luger A, Neuhold S, Wurm R, Adlbrecht C, Strunk G, Fritzer-Szekeres M, Prager R, Pacher R, Hülsmann M.
    Heart; 2016 Dec 15; 102(24):1963-1968. PubMed ID: 27456261
    [Abstract] [Full Text] [Related]

  • 11. Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes.
    Sawada R, Hashimoto Y, Senmaru T, Tanaka M, Ushigome E, Yamazaki M, Fukui M.
    Endocr Metab Immune Disord Drug Targets; 2018 Dec 15; 18(6):590-595. PubMed ID: 29697035
    [Abstract] [Full Text] [Related]

  • 12. Clinical Value of Natriuretic Peptides in Predicting Time to Dialysis in Stage 4 and 5 Chronic Kidney Disease Patients.
    Sundqvist S, Larson T, Cauliez B, Bauer F, Dumont A, Le Roy F, Hanoy M, Fréguin-Bouilland C, Godin M, Guerrot D.
    PLoS One; 2016 Dec 15; 11(8):e0159914. PubMed ID: 27548064
    [Abstract] [Full Text] [Related]

  • 13. Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.
    Bidadkosh A, Lambooy SPH, Heerspink HJ, Pena MJ, Henning RH, Buikema H, Deelman LE.
    Diabetes Care; 2017 Jun 15; 40(6):784-792. PubMed ID: 28341782
    [Abstract] [Full Text] [Related]

  • 14. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
    Pareek M, Bhatt DL, Vaduganathan M, Biering-Sørensen T, Qamar A, Diederichsen AC, Møller JE, Hindersson P, Leósdóttir M, Magnusson M, Nilsson PM, Olsen MH.
    Eur J Prev Cardiol; 2017 Oct 15; 24(15):1648-1659. PubMed ID: 28644092
    [Abstract] [Full Text] [Related]

  • 15. B-type natriuretic peptide concentrations predict the progression of nondiabetic chronic kidney disease: the Mild-to-Moderate Kidney Disease Study.
    Spanaus KS, Kronenberg F, Ritz E, Schlapbach R, Fliser D, Hersberger M, Kollerits B, König P, von Eckardstein A, Mild-to-Moderate Kidney Disease Study Group.
    Clin Chem; 2007 Jul 15; 53(7):1264-72. PubMed ID: 17478561
    [Abstract] [Full Text] [Related]

  • 16. Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.
    Kim Y, Matsushita K, Sang Y, Grams ME, Skali H, Shah AM, Hoogeveen RC, Solomon SD, Ballantyne CM, Coresh J.
    Am J Kidney Dis; 2015 Apr 15; 65(4):550-8. PubMed ID: 25446023
    [Abstract] [Full Text] [Related]

  • 17. Changes in Natriuretic Peptide Levels and Subsequent Kidney Function Decline in SPRINT.
    Ascher SB, Berry JD, Katz R, de Lemos JA, Bansal N, Garimella PS, Hallan SI, Wettersten N, Jotwani VK, Killeen AA, Ix JH, Shlipak MG.
    Am J Kidney Dis; 2024 May 15; 83(5):615-623.e1. PubMed ID: 37992982
    [Abstract] [Full Text] [Related]

  • 18. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
    Gregg LP, Adams-Huet B, Li X, Colbert G, Jain N, de Lemos JA, Hedayati SS.
    J Am Heart Assoc; 2017 Jul 05; 6(7):. PubMed ID: 28679558
    [Abstract] [Full Text] [Related]

  • 19. Estimated Glomerular Filtration Rate, Activation of Cardiac Biomarkers and Long-Term Cardiovascular Outcomes: A Population-Based Cohort.
    Vinnakota S, Scott CG, Rodeheffer RJ, Chen HH.
    Mayo Clin Proc; 2019 Nov 05; 94(11):2189-2198. PubMed ID: 31668448
    [Abstract] [Full Text] [Related]

  • 20. Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study.
    Lindholm D, James SK, Gabrysch K, Storey RF, Himmelmann A, Cannon CP, Mahaffey KW, Steg PG, Held C, Siegbahn A, Wallentin L.
    JAMA Cardiol; 2018 Dec 01; 3(12):1160-1166. PubMed ID: 30427997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.